期刊文献+

胆管癌血清肿瘤标志物与病理特征的相关性分析

Correlation between serum tumor markers and pathological features in cholangiocarcinoma
下载PDF
导出
摘要 目的探讨胆管癌(cholangiocarcinoma,CCA)患者病理特征和血清肿瘤标志物甲胎蛋白(alpha fetoprotein,AFP)、糖类抗原19-9(carbohydrate antigen 19-9,CA19-9)、癌胚抗原(carcinoembryonic antigen,CEA)和CA125之间的关系。方法对2012年10月至2020年5月在首都医科大学附属北京佑安医院经病理检查确诊的以胆管细胞来源为主的CCA患者359例进行回顾性研究,取患者空腹血清用电化学发光免疫法检测肿瘤标志物AFP、CA19-9、CEA和CA125水平。分析血清肿瘤标志物的表达与病理分型、病理分化程度、肿瘤直径、肿瘤位置、血管癌栓和转移路径等病理特征的关系。结果CCA患者AFP、CA19-9、CEA和CA125异常率分别为37.5%(116/309)、54.0(147/272)、27.4%(75/274)和38.5%(25/65)。肝细胞癌-胆管细胞癌混合癌患者(混合组)的AFP水平中位数高于单纯胆管细胞癌组患者(单纯组;7.87 ng/mL vs 4.05 ng/mL,P=0.030)。混合组高水平AFP者肿瘤均位于肝内且呈低分化。CA19-9异常在单纯组、有血管癌栓的患者和肿瘤直径≥5 cm的患者中更常见(均P<0.05),尤其高水平CA19-9(≥1000 U/mL)患者比例在单纯组高于混合组(15.1%vs 0.0%,P=0.012),其中单纯组高水平CA19-9者合并血管癌栓占60.6%,合并肿瘤直径≥5 cm占72.7%。CEA异常率在肿瘤位置为肝外、有血管癌栓、有淋巴结转移和有神经侵犯的患者中更常见(均P<0.05)。CA125异常率在有血管癌栓和肿瘤直径≥5 cm的患者中更常见(均P<0.05)。结论CCA患者病理分型、病理分化程度、肿瘤直径、肿瘤位置、血管淋巴结转移及神经侵犯等病理特征与血清肿瘤标志物AFP、CA19-9、CEA和CA125的表达密切相关。 Objective To analyse the correlation between serum tumor markers,including alpha fetoprotein(AFP),carbohydrate antigen 19-9(CA19-9),carcinoembryonic antigen(CEA)and CA125,and the pathological characteristics of cholangiocarcinoma(CCA)patients.Methods A retrospective study was conducted in 359 CCA patients confirmed by pathological examination,enrolled at Beijing YouAn Hospital,Capital Medical University,from October 2012 to May 2020.The levels of tumor markers including AFP,CA19-9,CEA and CA125 in fasting serum were detected by electrochemiluminescence immunoassay.The correlation between the tumor markers and pathological characteristics such as pathological type,pathological differentiation,tumor size,tumor location,vascular tumor thrombus and routes of metastasis was analyzed.Results The abnormal rates of AFP,CA19-9,CEA and CA125 in CCA patients were 37.5%(116/309),54.0(147/272),27.4%(75/274)and 38.5%(25/65),respectively.The median AFP level in combined hepatocellular-CCA(cHCC-CCA)patients was higher than that in patients with CCA alone(7.87 ng/mL vs 4.05 ng/mL,P=0.030).The tumors in cHCC-CCA patients with high level of AFP were all located in the liver and showed low differentiation.The abnormality of CA19-9 was higher in patients with CCA alone,vascular tumor thrombus and tumor diameter≥5 cm(all P<0.05).The proportion of patients with CA19-9 level≥1000 U/mL was higher in patients with CCA alone than that in cHCC-CCA patients(15.1%vs 0.0%,P=0.012).In patients with CCA alone and CA19-9 level≥1000 U/mL,60.6%of the patients were complicated with vascular tumor thrombus,and 72.7%of the patients had tumor diameters≥5 cm.The abnormal rate of CEA was higher in patients with extrahepatic tumors,vascular tumor thrombus,lymph node metastasis and peripheral nerve invasion(all P<0.05).The abnormal rate of CA125 was higher in patients with vascular tumor thrombus and tumor diameter≥5 cm(both P<0.05).Conclusions The expressions of serum tumor markers including AFP,CA19-9,CEA and CA125 were closely related to the pathological type,pathological differentiation,tumor size,tumor location,vascular lymph node metastasis and peripheral nerve invasion of CCA patients.
作者 伍慧丽 刘晖 刘梅 鲍旭丽 闾军 Wu Huili;Liu Hui;Liu Mei;Bao Xuli;Lv Jun(Internal Medicine-Oncology Department,Beijing YouAn Hospital,Capital Medical University,Beijing 100069,China;Pathology Department,Beijing YouAn Hospital,Capital Medical University,Beijing 100069,China)
出处 《实用肿瘤杂志》 CAS 2023年第6期550-557,共8页 Journal of Practical Oncology
基金 首都卫生发展科研专项项目(2018-1-2181) 首都临床特色应用研究(Z181100001718191) 北京市属医院科研培育项目(PX2019063) 北京市医院管理局临床医学发展专项(XMLX201830) 2021年度首都医科大学附属北京佑安医院院内课题青年项目(YNKYQN2021008)。
关键词 胆管癌 病理特征 肿瘤标志物 cholangiocarcinoma pathological features tumor markers
  • 相关文献

参考文献5

二级参考文献46

  • 1无,方驰华,刘允怡,曾宁,卢绮萍.肝门部胆管癌三维可视化精准诊治中国专家共识(2019版)[J].中国实用外科杂志,2020,40(3):260-266. 被引量:31
  • 2田伏洲,石力,汤礼军,汪涛,黎冬暄,邹树,罗皓.胰头癌术前减黄指征的前瞻性研究[J].中华外科杂志,2006,44(23):1614-1616. 被引量:49
  • 3Ahmet Mesrur Halefoglu.Magnetic resonance cholangiopancreatography: A useful tool in the evaluation of pancreatic and biliary disorders[J].World Journal of Gastroenterology,2007,13(18):2529-2534. 被引量:26
  • 4吴孟超.应重视小肝癌的诊断与治疗[J].中华医学杂志,2007,87(30):2089-2091. 被引量:11
  • 5Steiner PE, Higginson J. Cholangiolocellular carcinoma of the liver [J]. Cancer,1959, 12(4):753-759.
  • 6NakanumaY,-Curabo'MP, Franceschi S, et al. A intrahepatic cholangiocarcinoma[ M ]// Bosman FT, Carneiro F, Hruban RH, ed. World Health Organization of tumours of the digestive system. 4th ed. Lyon : IARC Press,2010:217-224.
  • 7Byrne JP, Bhatnagar S, Hamid B, et al. Comparative study of intestinal metaplasia and mucin staining at the cardia and esophagogastric junction in 225 symptonmtic patients presenting for diagnostic open-access gastroscopy [ J ]. Am J Gastroenterol, 1999,94( 1 ) :98-103.
  • 8Cai X, Zhai .1, Kaplan DE, et aL Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma[J]. Hepatology,2012,56(5) : 1804-1806. DOI: 10. 1002/hep. 25874.
  • 9Komuta M, Spee B, Vander Borght S, et al. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin[ J]. Hepatology, 2008,47 ( 5 ) : 1544-1556. DOI: 10. 1002/hep. 22238.
  • 10Tsuchiya A, Kamimura H, Tamura Y, et al. Hepatocellular carcinoma with progenitor cell features distinguishable by the hepatic stem/progenitor cell marker NCAM [ J ]. Cancer Lett, 2011,309 ( 1 ) :95-103. DOI : 10. 1016/j. canlet. 2011.05. 021.

共引文献150

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部